Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Recherche
  • icone plus

  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte

  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités

2 results

  • Active substance : aluminium
  • Date : ["2020-08-27" .. "2024-08-27"[
Filter
Topic
  • Diseases and conditions (2)
  • Plus ...
    • Infectious diseases (1)
    • Plus ...
      • (1)
      • Virus diseases (1)
    • Endocrine system and metabolic diseases (1)
    • Plus ...
      • Obesity (1)
  • Economics and public health (1)
  • Plus ...
    • Organisation of care (1)
  • Diagnostic and therapeutic techniques (1)
  • Plus ...
    • Vaccine (1)
    • Drug therapy (1)
  • Population groups (1)
  • Plus ...
    • Paediatrics (1)
Content type
  • Practice Guidelines and Other Guides (2)
  • Plus ...
    • Chronic disease guide (1)
    • Studies and Reports (1)
Date
  • Last five years (2)
Manufacturer
  • inconnu (1)
  • industriels (1)
Language
  • Français (2)
Active substance
  • alcool (1)
  • aluminium (2)
  • alun (1)
  • glycine (1)
  • levure (1)
  • phosphate (1)
  • polysorbate 80 (1)
  • proline (1)
 More filter Other Filter Icon
Search Export

Practice guidelines and other guides - 2 results

  • Care pathway guide: overweight and obesity in children and adolescents

    Chronic disease guide - Posted on 2/3/2022 - Mis à jour le 17/4/2023
    Download guide
    Add to my selection

  • Immunological and virological aspects of SARS-CoV-2 - Genetic variability, immune responses, vaccine platforms and animal models

    Studies and Reports - Posted on 1/12/2020
    Download report
    Add to my selection

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
ZH4XJqxt8FVtXXHZ